Newsroom
-
July 15 , 2020
Immunotherapy with CAR T cells results in exceptional patient recovery
- In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) T cells that were engineered to target the HER2 protein on the surface of the cancer cells.
Read more -
July 15 , 2020
Sylvester researchers identify protein target that might ease graft versus host disease
- In a new study published in Science Translational Medicine, Robert Levy, Ph.D., along with graduate student and first author Cameron Bader and colleagues, have shown that inhibiting the STING protein pathway could protect certain patients from graft versus host disease, the most serious complication from bone marrow (stem cell) transplants.
Read more -
July 15 , 2020
Boosting immune memory could reduce cancer recurrence
- Blocking a newly identified "immune memory checkpoint" in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine. The research was published this week in Nature Immunology.
Read more -
July 14 , 2020
First Coronavirus Vaccine Tested in Humans Shows Early Promise
- An experimental coronavirus vaccine made by the biotech company Moderna provoked a promising immune response against the virus and appeared safe in the first 45 people who received it, researchers reported on Tuesday in The New England Journal of Medicine.
Read more -
July 13 , 2020
Amgen Announces Additional Investment In BeiGene
- Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares
Read more